These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26731899)

  • 61. CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors.
    Salvador F; Gomis RR
    EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29789342
    [No Abstract]   [Full Text] [Related]  

  • 62. Corrigendum: Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming.
    Hirsch CL; Akdemir ZC; Wang L; Jayakumaran G; Trcka D; Weiss A; Hernandez JJ; Pan Q; Han H; Xu X; Xia Z; Salinger AP; Wilson M; Vizeacoumar F; Datti A; Li W; Cooney AJ; Barton MC; Blencowe BJ; Wrana JL; Dent SY
    Genes Dev; 2015 Jun; 29(12):1341. PubMed ID: 26109054
    [No Abstract]   [Full Text] [Related]  

  • 63. Aberrant splicing in B-cell acute lymphoblastic leukemia.
    Black KL; Naqvi AS; Asnani M; Hayer KE; Yang SY; Gillespie E; Bagashev A; Pillai V; Tasian SK; Gazzara MR; Carroll M; Taylor D; Lynch KW; Barash Y; Thomas-Tikhonenko A
    Nucleic Acids Res; 2019 Jan; 47(2):1043. PubMed ID: 30517739
    [No Abstract]   [Full Text] [Related]  

  • 64. The conundrum of discordant protein and mRNA expression. Are plants special?
    Vélez-Bermúdez IC; Schmidt W
    Front Plant Sci; 2014; 5():619. PubMed ID: 25426129
    [No Abstract]   [Full Text] [Related]  

  • 65. RNA ligands: out of shape but fir for recognition.
    Ellington AD
    Curr Biol; 1993 Jun; 3(6):375-7. PubMed ID: 15335736
    [No Abstract]   [Full Text] [Related]  

  • 66. Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages.
    Effenberger KA; Urabe VK; Prichard BE; Ghosh AK; Jurica MS
    RNA; 2016 Mar; 22(3):350-9. PubMed ID: 26742993
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy.
    Zahid MF; Patnaik MM; Gangat N; Hashmi SK; Rizzieri DA
    Eur J Haematol; 2016 Oct; 97(4):313-20. PubMed ID: 27147278
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting MYC in cancer therapy: RNA processing offers new opportunities.
    Koh CM; Sabò A; Guccione E
    Bioessays; 2016 Mar; 38(3):266-75. PubMed ID: 26778668
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of prognostic and bone metastasis​-related alternative splicing signatures in mesothelioma.
    Huang R; Zheng Z; Liu S; Yan P; Song D; Yin H; Hu P; Zhu X; Chang Z; Liu Y; Zhuang J; Meng T; Huang Z; Zhang J
    Cancer Med; 2021 Jul; 10(13):4478-4492. PubMed ID: 34041868
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification and Characterization of Alternatively Spliced Transcript Isoforms of
    Fernando A; Liyanage C; Moradi A; Janaththani P; Batra J
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33919200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An alternative splicing signature model for predicting hepatocellular carcinoma-specific survival.
    Dong S; Lu LJ
    J Gastrointest Oncol; 2020 Oct; 11(5):1054-1064. PubMed ID: 33209497
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Alternative Splicing Detection as Biomarker Candidates for Cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
    Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
    Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.
    Kajiwara T; Matsushita K; Itoga S; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Habara Y; Matsuo M; Nomura F
    Cancer Sci; 2013 Feb; 104(2):149-56. PubMed ID: 23113893
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy.
    Hahn CN; Venugopal P; Scott HS; Hiwase DK
    Immunol Rev; 2015 Jan; 263(1):257-78. PubMed ID: 25510282
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
    Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
    Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
    Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
    Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.